Established in 2023, KP Rx is a 100% founder-owned investment firm specialising in private and early-stage public healthcare investments in Australia and New Zealand. Founded by Hashan De Silva and backed by Karst Peak Capital, the firm targets high-potential biotech, medical devices, diagnostics, and health tech companies at a pivotal inflection point of value creation.
Our Focus
Creating a portfolio of Australia’s most promising healthcare companies. Our focus is on companies at or after Series A, specifically biotech companies at Phase 2 or medical device companies at or after regulatory clearance.
- Small-molecule Drugs
- Biological Products
- Cell & Gene Therapies
- Medical Devices
- Diagnostic Technologies
- AI for Healthcare
- Healthcare Software / SaaS
- Data and Analytics